IDR 50.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 6.66 Billion | -14.25 Billion | -4.56 Billion | 11.26 Billion | 7.62 Billion | 5.5 Billion |
Net Income | 9.5 Billion | 7.86 Billion | 6.17 Billion | 5.75 Billion | 3.59 Billion | 2.84 Billion |
Depreciation & Amortization | 4.8 Billion | 4.61 Billion | 3.87 Billion | 2.54 Billion | 2.31 Billion | 2.28 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -7.64 Billion | -17.51 Billion | -6.86 Billion | 8.05 Billion | 6.35 Billion | 4.94 Billion |
Investing Cash Flow | -1.05 Billion | -4.6 Billion | -18.43 Billion | -2.01 Billion | -2.78 Billion | -1.05 Billion |
Investments in PPE | -1.22 Billion | -4.64 Billion | -18.65 Billion | -2.11 Billion | -2.78 Billion | -1.06 Billion |
Acquisitions | 166.66 Million | 32 Million | 223.5 Million | 100 Million | - | 500 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 166.66 Million | 32 Million | 223.5 Million | 100 Million | - | 500 Thousand |
Financing Cash Flow | -14.63 Billion | -3.96 Billion | 69.67 Billion | -5.04 Billion | -4.39 Billion | -3.05 Billion |
Debt repayment | -3.2 Billion | -1.5 Billion | -387.97 Million | -908.75 Million | -728.26 Million | -200.51 Million |
Dividends payments | -2.06 Billion | -1.29 Billion | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 59.4 Million | 72.51 Billion | - | - | - |
Other Financing Activities | -9.35 Billion | -1.44 Billion | 72.9 Billion | -729.88 Million | -245.07 Million | 635.75 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 33.83 Billion | 56.66 Billion | 9.97 Billion | 5.76 Billion | 5.31 Billion | - |
Cash at end of period | 24.8 Billion | 33.83 Billion | 56.66 Billion | 9.97 Billion | 5.76 Billion | 5.31 Billion |
Capital Expenditure | -1.22 Billion | -4.64 Billion | -18.65 Billion | -2.11 Billion | -2.78 Billion | -1.06 Billion |
Effect of forex changes on cash | - | - | - | - | - | 3.91 Billion |
Net cash flow / Change in cash | -9.02 Billion | -22.83 Billion | 46.68 Billion | 4.21 Billion | 449.76 Million | 5.31 Billion |
Free Cash Flow | 5.44 Billion | -18.89 Billion | -23.21 Billion | 9.15 Billion | 4.84 Billion | 4.44 Billion |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 596.41 Million | 1.69 Billion | 1.43 Billion | 9.5 Billion | 5.86 Billion | 833.54 Million |
Depreciation & Amortization | 1.17 Billion | 1.15 Billion | 1.13 Billion | 4.8 Billion | 1.24 Billion | 1.12 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 12.06 Billion | -10.16 Billion | 7.58 Billion | 1.96 Billion | -8.57 Billion | 10.74 Billion |
Investing Cash Flow | -66.37 Million | 168.1 Million | -434.18 Million | -1.05 Billion | 586.39 Million | -33.37 Million |
Investments in PPE | -66.37 Million | 168.1 Million | -434.18 Million | -1.22 Billion | 604.72 Million | -73.37 Million |
Acquisitions | - | - | - | 166.66 Million | -18.33 Million | 40 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | 166.66 Million | -18.33 Million | 40 Million |
Financing Cash Flow | -7.21 Billion | 2.35 Billion | 7.7 Billion | -14.63 Billion | 21.17 Billion | -40.23 Billion |
Debt repayment | -7.41 Billion | -786.45 Million | -7.76 Billion | -9.35 Billion | -21.54 Billion | -37.89 Billion |
Dividends payments | - | -3.23 Billion | - | -2.06 Billion | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 192.9 Million | 6.36 Billion | 7.76 Billion | -9.35 Billion | 21.17 Billion | -40.23 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 35.17 Billion | 39.96 Billion | 24.8 Billion | 33.83 Billion | 6.99 Billion | 36.8 Billion |
Cash at end of period | 41.72 Billion | 35.17 Billion | 39.96 Billion | 24.8 Billion | 24.8 Billion | 6.99 Billion |
Capital Expenditure | -66.37 Million | 168.1 Million | -434.18 Million | -1.22 Billion | 604.72 Million | -73.37 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 6.54 Billion | -4.79 Billion | 15.15 Billion | -9.02 Billion | 17.81 Billion | -29.81 Billion |
Free Cash Flow | 13.76 Billion | -7.14 Billion | 7.45 Billion | 5.44 Billion | -3.34 Billion | 10.38 Billion |
HINDBIO
INDO
603379
ACMTA
5201
WTBA